Nihon Chouzai Co.,Ltd. (TSE:3341) agreed to acquire remaining 44.71% stake in Choseido Pharmaceutical Co., Ltd. for ¥5.8 billion on October 21, 2021. Nihon Chouzai Co., Ltd. announces that it passed a resolution at its Board of Directors' meeting held on October 21, 2021 to transfer all of its shares in consolidated subsidiary Choseido Pharmaceutical Co., Ltd. to consolidated subsidiary Nihon Generic Co., Ltd. As a result of this share transfer, Choseido Pharmaceutical will become a subsidiary of Nihon Generic and a consolidated sub-subsidiary of Nihon Generic, and will continue to be included in the scope of consolidation of Nihon Generic. The share transfer is not expected to have any material impact on consolidated financial results for the fiscal year ending March 31, 2022, but Nihon Generic will promptly make an announcement should matters requiring disclosure arise.

Execution date of share transfer is planned on November 30, 2021.